SynKIR-310 for Relapsed/Refractory B-NHL
Verismo Therapeutics
Verismo Therapeutics
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
ModeX Therapeutics, An OPKO Health Company
LTZ Therapeutics, Inc.
Haihe Biopharma Co., Ltd.
Eli Lilly and Company
GenomeFrontier Therapeutics TW Co., Ltd.
H. Lee Moffitt Cancer Center and Research Institute
Istituto Oncologico Veneto IRCCS
University of Arizona
Ipsen
Memorial Sloan Kettering Cancer Center
Mayo Clinic
University of Nebraska
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Hospices Civils de Lyon
Insel Gruppe AG, University Hospital Bern
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Ipsen
The First Affiliated Hospital of Xiamen University
Cyteir Therapeutics, Inc.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Australasian Leukaemia and Lymphoma Group
Atara Biotherapeutics
Roswell Park Cancer Institute
Swiss Cancer Institute
Rutgers, The State University of New Jersey
Gilead Sciences
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Novartis
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center